NCT07531160

Brief Summary

This observational study aims to identify baseline factors that predict clinical response at six months in patients with knee osteoarthritis treated with radial pressure wave therapy (rESWT). The study is a secondary analysis of data obtained from a randomized double-blind clinical trial conducted in 2024 at a tertiary care hospital in Mexico. Knee osteoarthritis is a common condition that causes pain, stiffness, and reduced physical function. Radial pressure wave therapy is a non-invasive treatment that has shown benefits in improving symptoms; however, not all patients respond equally. This study will analyze patient characteristics at baseline, such as age, body mass index, pain severity, and functional status, to determine which factors are associated with meaningful improvement in pain and function after treatment. The results may help clinicians better identify which patients are more likely to benefit from this therapy and improve personalized treatment decisions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 19, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 26, 2024

Completed
25 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2025

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

April 9, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 15, 2026

Completed
Last Updated

April 15, 2026

Status Verified

April 1, 2026

Enrollment Period

1 month

First QC Date

April 9, 2026

Last Update Submit

April 9, 2026

Conditions

Keywords

Radial Pressure Wave TherapyrESWTShockwave TherapyKnee OsteoarthritisPredictorsClinical ResponsePrognostic Factors

Outcome Measures

Primary Outcomes (1)

  • Achievement of minimal clinically important difference (MCID) in pain intensity measured by the Numerical Pain Rating Scale (NPRS)

    The proportion of patients achieving the minimal clinically important difference (MCID) in pain intensity measured using the Numerical Pain Rating Scale (NPRS), a validated 0 to 10 scale where higher scores indicate greater pain.

    6 months after baseline

Secondary Outcomes (3)

  • Achievement of minimal clinically important difference (MCID) in pain intensity measured by the Numerical Pain Rating Scale (NPRS)

    6 months after baseline

  • Change in WOMAC score over time

    Baseline, 2 months, 4 months, and 6 months

  • Change in pain intensity measured by the Numerical Pain Rating Scale (NPRS) over time

    Baseline, 2 months, 4 months, and 6 months

Study Arms (1)

Patients with knee osteoarthritis treated with radial pressure wave therapy

Adult patients with clinically and radiographically diagnosed knee osteoarthritis who participated in a randomized double-blind clinical trial evaluating radial pressure wave therapy (rESWT) in 2024. This cohort includes participants with complete baseline and follow-up data up to six months and is used to identify baseline predictors of clinical response.

Procedure: Radial Pressure Wave Therapy

Interventions

Radial pressure wave therapy (rESWT) administered according to standardized protocols in the original randomized clinical trial. The therapy involves the application of acoustic waves to the knee joint to reduce pain and improve function.

Patients with knee osteoarthritis treated with radial pressure wave therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients with clinically and radiographically confirmed knee osteoarthritis who participated in a randomized double-blind clinical trial evaluating radial pressure wave therapy (rESWT) at a tertiary care hospital in Mexico in 2024. Only participants with complete baseline and six-month follow-up data are included in this secondary analysis.

You may qualify if:

  • Clinical and radiographic diagnosis of knee osteoarthritis
  • Participation in the original randomized double-blind clinical trial evaluating radial pressure wave therapy (rESWT) in 2024
  • Availability of complete baseline data
  • Availability of follow-up data up to 6 months

You may not qualify if:

  • Incomplete baseline or follow-up data
  • Withdrawal from the original trial before completion
  • Missing outcome measurements required for analysis
  • Presence of conditions that could interfere with outcome assessment or data validity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Civil de Guadalajara Fray Antonio Alcalde

Guadalajara, Jalisco, 44280, Mexico

Location

Related Publications (4)

  • Melese H, Alamer A, Getie K, Nigussie F, Ayhualem S. Extracorporeal shock wave therapy on pain and foot functions in subjects with chronic plantar fasciitis: systematic review of randomized controlled trials. Disabil Rehabil. 2022 Sep;44(18):5007-5014. doi: 10.1080/09638288.2021.1928775. Epub 2021 May 26.

  • Charles R, Fang L, Zhu R, Wang J. The effectiveness of shockwave therapy on patellar tendinopathy, Achilles tendinopathy, and plantar fasciitis: a systematic review and meta-analysis. Front Immunol. 2023 Aug 16;14:1193835. doi: 10.3389/fimmu.2023.1193835. eCollection 2023.

  • Li H, Xiong Y, Zhou W, Liu Y, Liu J, Xue H, Hu L, Panayi AC, Mi B, Liu G. Shock-wave therapy improved outcome with plantar fasciitis: a meta-analysis of randomized controlled trials. Arch Orthop Trauma Surg. 2019 Dec;139(12):1763-1770. doi: 10.1007/s00402-019-03262-z. Epub 2019 Aug 21.

  • Vahdatpour B, Sajadieh S, Bateni V, Karami M, Sajjadieh H. Extracorporeal shock wave therapy in patients with plantar fasciitis. A randomized, placebo-controlled trial with ultrasonographic and subjective outcome assessments. J Res Med Sci. 2012 Sep;17(9):834-8.

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Armando Tonatiuh Avila Garcia, MD

    Hospital Civil de Guadalajara

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief Department of Physical Medicine and Rehabilitation

Study Record Dates

First Submitted

April 9, 2026

First Posted

April 15, 2026

Study Start

November 19, 2024

Primary Completion

December 26, 2024

Study Completion

January 20, 2025

Last Updated

April 15, 2026

Record last verified: 2026-04

Locations